NCT00092859View on ClinicalTrials.gov

A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,500

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Obesity

Interventions

DRUG

MK0557

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00092859 - A 2-Year Study of an Investigational Drug in Obese Patients (0557-011) | Biotech Hunter | Biotech Hunter